FAQ/Help |
Calendar |
Search |
Today's Posts |
08-14-2017, 10:11 PM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
Medscape Diabetes Drug May Slow Parkinson's Disease Medscape The type 2 diabetes drug exenatide (Bydureon, Byetta, AstraZeneca) has potential disease-modifying effects in Parkinson's disease, results of a randomized, double-blind, placebo-controlled trial suggest. Study results show the glucagon-like peptide-1 ... More... |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
New Drug May Slow Progression of Parkinson's Disease - Newsmax | Parkinson's News | |||
Type 2 Diabetes Drug Could Slow Parkinson's Disease Progression, Human Trials To Begi | Parkinson's News | |||
Parkinson's Disease Cure Update: Diabetes Drug That May Slow Progression Is Being Rea | Parkinson's News | |||
Diabetes drug slows experimental Parkinson's disease | Parkinson's Disease | |||
New Parkinson's Drug Could Slow Disease Progression | Parkinson's Disease |